
Sign up to save your podcasts
Or


In this episode of Cutaneous Miscellaneous, host Nicholas Brownstone, MD, is joined by Ryan Svoboda, MD, for an in-depth review of cutaneous lymphomas.
They begin with a boards review of the four primary cutaneous B-cell lymphomas—two indolent (follicle center, marginal zone) and two aggressive (diffuse large B-cell, intravascular B-cell). The discussion covers prognostic differences, biopsy strategies, key immunostains, helpful mnemonics for BCL markers, and notable associations such as Borrelia infection.
In the main segment, the focus shifts to cutaneous T-cell lymphomas, particularly mycosis fungoides. Dr Svoboda shares diagnostic challenges, strategies to improve biopsy yield, and a practical scoring algorithm to interpret inconclusive pathology reports. They also review tips for diagnosing Sézary syndrome and highlight relevant NCCN guidelines.
Tune in to the full episode for high-yield insights on recognizing, diagnosing, and managing both B-cell and T-cell cutaneous lymphomas in clinical practice.
By Dermsquared5
66 ratings
In this episode of Cutaneous Miscellaneous, host Nicholas Brownstone, MD, is joined by Ryan Svoboda, MD, for an in-depth review of cutaneous lymphomas.
They begin with a boards review of the four primary cutaneous B-cell lymphomas—two indolent (follicle center, marginal zone) and two aggressive (diffuse large B-cell, intravascular B-cell). The discussion covers prognostic differences, biopsy strategies, key immunostains, helpful mnemonics for BCL markers, and notable associations such as Borrelia infection.
In the main segment, the focus shifts to cutaneous T-cell lymphomas, particularly mycosis fungoides. Dr Svoboda shares diagnostic challenges, strategies to improve biopsy yield, and a practical scoring algorithm to interpret inconclusive pathology reports. They also review tips for diagnosing Sézary syndrome and highlight relevant NCCN guidelines.
Tune in to the full episode for high-yield insights on recognizing, diagnosing, and managing both B-cell and T-cell cutaneous lymphomas in clinical practice.

3,471 Listeners

2,445 Listeners

3,348 Listeners

56,532 Listeners

16 Listeners

165,823 Listeners

35 Listeners

382 Listeners

132 Listeners

6 Listeners

52 Listeners

20,203 Listeners

6 Listeners

3 Listeners

33 Listeners